Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$1.5 - $3.45 $26,500 - $60,951
-17,667 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$2.41 - $6.9 $12,107 - $34,665
-5,024 Reduced 22.14%
17,667 $49,000
Q4 2021

Feb 14, 2022

BUY
$5.1 - $12.98 $115,724 - $294,529
22,691 New
22,691 $143,000

Others Institutions Holding CGTX

About COGNITION THERAPEUTICS INC


  • Ticker CGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,710,700
  • Market Cap $9.99M
  • Description
  • Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...
More about CGTX
Track This Portfolio

Track Apogem Capital LLC Portfolio

Follow Apogem Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apogem Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apogem Capital LLC with notifications on news.